The adjusted EBITDA loss improved from a loss of $508,806 in Q2-2024 to a loss of $217,816 in Q2-2025. The variation is explained by the operational expenses decrease (Selling, General & ...

The Company has an authorized share repurchase program for up to $250.0 million of the Company’s common stock on or before September 21, 2026. In the fiscal third quarter of 2025, Anterix had share ...

In the fourth quarter of 2024, seasonally adjusted GDP increased by 0.1% in the EU, compared with the previous quarter. In ...